D. E. Shaw & Co., Inc. Adicet Bio, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 505,469 shares of ACET stock, worth $353,828. This represents 0.0% of its overall portfolio holdings.

Number of Shares

505,469

Previous 847,064 40.33%

Holding current value

$353,828

Previous $813,000 52.77%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.76 - $1.09 $259,612 - $372,338	-341,595 Reduced 40.33%	505,469 $384,000
Q4 2024 Feb 14, 2025	SELL	$0.86 - $1.52 $60,205 - $106,409	-70,006 Reduced 7.63%	847,064 $813,000
Q3 2024 Nov 14, 2024	BUY	$1.07 - $1.63 $86,704 - $132,082	81,032 Added 9.69%	917,070 $1.32 Million
Q2 2024 Aug 14, 2024	BUY	$1.21 - $2.4 $617,207 - $1.22 Million	510,089 Added 156.49%	836,038 $1.01 Million
Q1 2024 May 15, 2024	SELL	$1.76 - $3.45 $36,379 - $71,311	-20,670 Reduced 5.96%	325,949 $765,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $112,938 - $192,299	101,746 Added 41.55%	346,619 $655,000
Q3 2023 Nov 14, 2023	BUY	$1.37 - $3.4 $292,384 - $725,624	213,419 Added 678.51%	244,873 $335,000
Q2 2023 Aug 14, 2023	SELL	$2.13 - $7.13 $28,011 - $93,766	-13,151 Reduced 29.48%	31,454 $76,000
Q1 2023 May 15, 2023	BUY	$5.52 - $9.23 $246,219 - $411,704	44,605 New	44,605 $256,000
Q3 2022 Nov 14, 2022	SELL	$13.43 - $18.74 $2.95 Million - $4.11 Million	-219,457 Reduced 66.14%	112,355 $1.6 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $1.14 Million - $2.3 Million	110,685 Added 50.05%	331,812 $4.84 Million
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $99,965 - $173,139	8,670 Added 4.08%	221,127 $4.42 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $1.24 Million - $2.95 Million	168,586 Added 384.28%	212,457 $3.72 Million
Q3 2021 Nov 15, 2021	SELL	$6.29 - $9.93 $177,145 - $279,658	-28,163 Reduced 39.1%	43,871 $344,000
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $363,446 - $629,999	39,548 Added 121.74%	72,034 $741,000
Q1 2021 May 17, 2021	BUY	$12.12 - $17.17 $96,584 - $136,827	7,969 Added 32.5%	32,486 $425,000
Q4 2020 Feb 16, 2021	BUY	$10.36 - $14.77 $126,630 - $180,533	12,223 Added 99.42%	24,517 $344,000
Q3 2020 Nov 16, 2020	BUY	$10.18 - $21.4 $125,152 - $263,091	12,294 New	12,294 $146,000

Others Institutions Holding ACET

# of Institutions

Shares Held

57.5M

Call Options Held

36.9K

Put Options Held

16.5K

View Full List

About Adicet Bio, Inc.

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $28M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

More about ACET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account